Tenjarla Srini bought SER
February 3, 2026 · Form 4 insider transaction
Tenjarla Srini bought 69,000 shares of Serina Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 14 days after the transaction.
Direction
Acquired (buy-side)
Shares
69,000
Price
$0.00
Total value
N/A
InsiderTenjarla Srini
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 3, 2026
Filing dateFebruary 17, 2026
Shares owned after69,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Unless otherwise terminated as provided in the optionee's option agreement, 12/48ths of the shares subject to the option shall vest twelve months after the Vesting Commencement Date, and 1/48th of the shares subject to the option shall vest on the same calendar day of each subsequent month thereafter until the shares subject to the option are fully vested.